Camellia PLC
18 April 2007
Camellia Plc
Disposal of Investment
18th April 2007
Getaz Romang Holding AG ('Getaz Romang'), a company listed on the Swiss Stock
Exchange in which Lawrie International Limited ('Lawrie'), a Bermudian wholly
owned subsidiary of Camellia Plc, holds 12,340 shares (approximately 2.50%) has
been the subject of a successful public tender offer by CRH Europe Holding BV
('CRH'). Getaz Romang is a leading buildings material distributor in
Switzerland.
CRH has announced that it now controls 96.79% of the share capital of Getaz
Romang but that the offer remains open subject to the fulfillment of certain
procedural conditions with the offer expected to be settled on 18th May 2007.
Lawrie expects to receive at present exchange rates approximately £5.8million
for its shares in Getaz Romang of which around £4.9million is profit. Part of
the proceeds will be used by Lawrie to reduce bank borrowings.'
For further enquiries please contact Camellia Plc
Malcolm Perkins, Chairman
01622 746655
18th April 2007
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.